SYNGENE INTERNATIONAL LIMITED UNIT II BLOCK S. 11

SYNGENE INTERNATIONAL LIMITED UNIT II BLOCK S. 11 is a manufacturing facility.

Syngene International Limited is a leading integrated research, development, and manufacturing organization (CRDMO) based in India. The company provides comprehensive scientific services from discovery to development and manufacturing for novel molecular entities. It partners with global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical companies. Its capabilities include discovery chemistry and biology, development, and manufacturing of small molecules, biologics, and oligonucleotides. UNIT II BLOCK S. 11 represents one of its operational sites, which contributes to its overall capacity for research, process development, and commercial manufacturing, making it fundamentally a factory that produces various compounds and products for its clients.

SYNGENE INTERNATIONAL LIMITED UNIT II BLOCK S. 11 provides a comprehensive range of contract research, development, and manufacturing services to pharmaceutical, biotechnology, and animal health companies. They do not produce or sell consumer-facing products under their own brand. Instead, their "products" are the specialized services and deliverables they offer to their clients, which include:

Discovery Research Services

Preclinical Development Services

Clinical Development Support Services

Manufacturing of Drug Substances (APIs) and Intermediates

Integrated Drug Discovery and Development Solutions

Biologics Development and Manufacturing Services

Small Molecule Development and Manufacturing Services

Oligonucleotide Development and Manufacturing Services

Analytical Development Services

Formulation Development Services

Process Development and Optimization Services

Quality Control and Assurance Services